tiprankstipranks
Advertisement
Advertisement

HK:6660 Stock Latest News

AIM Vaccine Seeks Approval for High-Potency Human Diploid Cell Rabies Shot
Company AnnouncementsAIM Vaccine Seeks Approval for High-Potency Human Diploid Cell Rabies Shot
49m ago
6660
AIM Vaccine Interim Revenue Slides as Losses Narrow Slightly
PremiumCompany Announcements
AIM Vaccine Interim Revenue Slides as Losses Narrow Slightly
14h ago
6660
AIM Vaccine Revises Domestic Share Issuance and Secures Key Subscriptions
PremiumCompany Announcements
AIM Vaccine Revises Domestic Share Issuance and Secures Key Subscriptions
5d ago
6660
AIM Vaccine Seeks Shareholder Nod for Private Domestic Share Issue and Dual Mainland Listings
PremiumCompany Announcements
AIM Vaccine Seeks Shareholder Nod for Private Domestic Share Issue and Dual Mainland Listings
5d ago
6660
AIM Vaccine Sets August Board Meeting to Approve Interim Results and Consider Dividend
PremiumCompany Announcements
AIM Vaccine Sets August Board Meeting to Approve Interim Results and Consider Dividend
12d ago
6660
AIM Vaccine Advances Serum-Free Rabies Shot Toward China Market Approval
PremiumCompany AnnouncementsAIM Vaccine Advances Serum-Free Rabies Shot Toward China Market Approval
21d ago
6660
AIM Vaccine Wins Strong Shareholder Backing for 2025 Results and Board Changes
Premium
Company Announcements
AIM Vaccine Wins Strong Shareholder Backing for 2025 Results and Board Changes
2M ago
6660
AIM Vaccine Details Board Structure and Governance Committees
Premium
Company Announcements
AIM Vaccine Details Board Structure and Governance Committees
2M ago
6660
AIM Vaccine Wins Shareholder Backing for Mainland Share Issue and Dual-Market Push
PremiumCompany Announcements
AIM Vaccine Wins Shareholder Backing for Mainland Share Issue and Dual-Market Push
2M ago
6660
AIM Vaccine Books Impairments as It Pauses mRNA Rabies Projects and Delays PCV13 Launch
PremiumCompany Announcements
AIM Vaccine Books Impairments as It Pauses mRNA Rabies Projects and Delays PCV13 Launch
3M ago
6660
AIM Vaccine Seeks Shareholder Nod for RMB Share Issue and Dual Listing on NEEQ and Beijing Bourse
PremiumCompany Announcements
AIM Vaccine Seeks Shareholder Nod for RMB Share Issue and Dual Listing on NEEQ and Beijing Bourse
3M ago
6660
AIM Vaccine Reshapes Board with New Director Nominations After Resignation
PremiumCompany Announcements
AIM Vaccine Reshapes Board with New Director Nominations After Resignation
3M ago
6660
AIM Vaccine Sets 2025 AGM to Approve Results, Board Changes and Capital Mandates
PremiumCompany AnnouncementsAIM Vaccine Sets 2025 AGM to Approve Results, Board Changes and Capital Mandates
3M ago
6660
AIM Vaccine Swings to Deeper 2025 Loss on Impairments and Revenue Decline
Premium
Company Announcements
AIM Vaccine Swings to Deeper 2025 Loss on Impairments and Revenue Decline
5M ago
6660
AIM Vaccine Plans Beijing A-Share Listing and New Domestic Share Issuance
Premium
Company Announcements
AIM Vaccine Plans Beijing A-Share Listing and New Domestic Share Issuance
5M ago
6660
AIM Vaccine Sets March 30 Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
AIM Vaccine Sets March 30 Board Meeting to Approve 2025 Results and Consider Dividend
5M ago
6660
AIM Vaccine Clears Key Regulatory Hurdle for World’s First Serum-Free Rabies Shot
PremiumCompany Announcements
AIM Vaccine Clears Key Regulatory Hurdle for World’s First Serum-Free Rabies Shot
7M ago
6660
AIM Vaccine Wins Approval to Start Trials of 20-Valent Pneumococcal Shot
PremiumCompany Announcements
AIM Vaccine Wins Approval to Start Trials of 20-Valent Pneumococcal Shot
7M ago
6660
AIM Vaccine Advances High-Potency Human Diploid Rabies Shot After Completing Phase III On-Site Work
PremiumCompany Announcements
AIM Vaccine Advances High-Potency Human Diploid Rabies Shot After Completing Phase III On-Site Work
7M ago
6660
AIM Vaccine Reshuffles Company Secretary and Authorised Representative Roles
PremiumCompany AnnouncementsAIM Vaccine Reshuffles Company Secretary and Authorised Representative Roles
8M ago
6660
AIM Vaccine Reports Interim Results with Decreased Revenue and Improved Loss Management
Premium
Company Announcements
AIM Vaccine Reports Interim Results with Decreased Revenue and Improved Loss Management
12M ago
6660
AIM Vaccine Co., Ltd. Schedules Board Meeting to Review Interim Results
Premium
Company Announcements
AIM Vaccine Co., Ltd. Schedules Board Meeting to Review Interim Results
1y ago
6660

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >